Program Highlights

More News

The Largest Most Experienced Blood Cancer and Transplant Program in the Region

The Colorado Blood Cancer Institute (CBCI) is a new program established by the expert physicians who have served Rocky Mountain Blood and Marrow Transplant Program patients for more than 15 years. CBCI was developed to provide state-of-the-art treatment for blood cancers such as leukemia, lymphoma and multiple myeloma.

CBCI is a FACT-accredited program for both autologous and allogeneic transplants, performing related and unrelated donor transplants including cord blood transplants. In 2011, CBCI performed its 2,000th bone marrow transplant, making it the largest full service stem cell and bone marrow transplant program in Colorado and among the top programs in the country.

CBCI conducts cutting edge clinical research, testing innovative treatments for patients with blood cancers and bone marrow diseases. Referral to a blood cancer specialist early after diagnosis allows for full evaluation of treatment options and the development of a treatment plan including access to approximately 50 clinical trials. The physicians and staff can discuss research studies to ensure that patients receive the most progressive therapies available.

In addition to our physicians, our transplant team includes a nationally recognized psychosocial team led by Teri Simoneau, Ph.D. Psychologists, social workers, dietitians, nurse practitioners, medical assistants, financial and transplant nurse coordinators, oncology certified registered nurses and volunteers provide services to patients and their families at many stages of their treatment process in both inpatient and outpatient settings. Our Long-Term Follow-Up Program advises and helps manage recovery after transplant including vaccinations, wellness and late complications of transplant.

The physicians and staff at the Colorado Blood Cancer Institute provide compassionate, personalized care, treating each person with a customized care plan. Our Physicians take referrals for new patients as well as for patients seeking a second opinion on their care.

Dr. Jennifer CaspariIn It For The Long Haul

A Support and Wellness Group for Individuals Diagnosed with
Multiple Myeloma

Uncertainty is a part of living with Multiple Myeloma. This weekly group will  help you manage stress and fear through support and connection with others.

Please join us! *Registration is required. 

Dates: Tuesdays, June 4-July 24
Time: 1:00-2:15 pm
Where: Presbyterian/ St. Luke’s Hospital Denver, Colorado - Specific location to be determined. 
For information, directions or to register, please call Jennifer Caspari, Ph.D at 720-754-4856
or email Jennifer.Caspari@HealthOneCares.com

Penny Bristol and Dr. MatousSGN-35 or Adcetris Approved

SGN-35 or Adcetris has been approved for two types of lymphoma: Hodgkin and a rare type of T-cell lymphoma. Dr. Jeffery Matous and patient Penny Bristol discuss treatment for her long battle against Hodgkin lymphoma.

Read more in the Denver Post

Blood Cancer Institute Adds Distinguished Doctor

Dr. Richard NashThe Colorado Blood Cancer Institute is proud to announce Dr. Richard Nash has joined the CBCI staff. Dr. Nash comes from the distinguished Fred Hutchinson Cancer Research Center. For more information about his background and career please...Read More